v3.26.3
Investments in and Advances to Joint Ventures - Summary of Financial Statement Impact From Changes In Estimates on an Unconsolidated Joint Venture (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Schedule of Equity Method Investments [Line Items]        
Operating loss $ 103,819 $ 107,955 $ 200,788 $ 312,849
Net Income (Loss) $ 54,153 $ 64,123 $ 91,860 $ 185,556
Diluted loss per share $ 0.51 $ 0.59 $ 0.85 $ 1.69
Unconsolidated Joint Ventures        
Schedule of Equity Method Investments [Line Items]        
Net Income (Loss) $ 47,407 $ 44,473 $ 12,383 $ 82,647
Unconsolidated Joint Ventures | Critical Infrastructure        
Schedule of Equity Method Investments [Line Items]        
Operating loss 0 0 (40,854) (14,478)
Net Income (Loss) $ 0 $ 0 $ (35,053) $ (10,869)
Diluted loss per share $ 0 $ 0 $ (0.33) $ (0.1)